Strivectin-SD's US advertising references a Dr. Nathalie Chevreau ("Director of Women's Health at Basic Research, LLC") and Dr. Daniel B. Mowrey (Director of Scientific Affairs at Strivectin manufacturer Klein-Becker).
The two companies in purportedly even-handed dialogue with one another are one and the same.
Moreover neither individual quoted is a medical doctor: Nathalie Chevreau is a registered dietician and Daniel B. Mowrey holds a PhD in experimental psychology (he has taught courses in experimental psychology, psychopharmacology, physiological psychology, sensation, cognition, and statistics).
This hasn't been clarified anywhere — its dishonest to lead the public, beauty therapists and medical doctors such as dermatologists to believe these people are representative of any portion of the medical community.
Despite legal action by the US Federal Trade Commission and media interest dating back to 2004, Dr. Daniel B. Mowrey's name continues to be plastered over literature for new products such as "Idebenol" (ripe for convenient confusion with recent prominent medical studies into the antioxidant "idebenone") and "Hylexin" from "Bremenn Research Lab" — a product for "serious dark circles."
This flavour of confusion is common to many products falling under the cosmeceutical category.